EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR ‐T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages

Yao Qi iD, Xuemei Fan, Jia Wang, Xin Li iD, Juan Mu, Rui Cui iD, Qi Deng iD

Journal of Cellular and Molecular Medicine · 2026-08 · 30 (15)

DOI: 10.1111/jcmm.71296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 29.07.2026. Verfasst von Yao Qi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tianjin First Central Hospital, School of Medicine and Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Macrophages, Lymphoma, Large B-Cell, Diffuse, Protein Kinase Inhibitors, Agammaglobulinaemia Tyrosine Kinase. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Health Research Project, Chinese Society of Clinical Oncology Beijing Xisike Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumour microenvironment (TME) of relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) patients is associated with resistance of DLBCL cells to CD19 CAR‐T cells. How to improve TME in DLBCL and improve the efficacy of CAR‐T cell therapy remains to be further explored. We observed the sensitivity of HBL‐1/U2932 cells pretreated with BTK inhibitors (BTKi) to CAR‐T cells with flow cytometry (FCM). The effect of pretreatment of BTKi on the polarisation state of alternative activated M2 macrophages was observed with FCM, real‐time PCR and Western blot method. The effect of Notch1 agonist on expressions of Arg‐1 protein, iNOS protein, Notch1 protein and RBP‐J protein in alternative activated M2 macrophages was observed by Western blot method. Then the expression consistency of Notch‐1 and RBP‐J in activated M2 macrophages was observed by siRNA transfection of Notch‐1. The cytotoxicity of CD19 CAR‐T cells on HBL‐1/U2932 cells pretreated with ibrutinib/orelabrutinib was higher than that of HBL‐1/U2932 cells unpretreated with ibrutinib/orelabrutinib. Cytotoxicity of CAR‐T cells to HBL‐1 cells in coculture system with alternative activated M2 macrophages was very low. This drug resistance could be reversed by replacing the M2 macrophages (M2 macrophages after 48 h pretreatment with BTKi) in coculture system. Pretreatment with BTKi could down‐regulate the expression of CD206 and IL‐10 in activated M2 macrophages. And pretreatment with BTKi down‐regulated the expression of Arg‐1 and upregulated the expression of iNOS in activated M2 macrophages. The upregulation polarisation of M2 macrophages by Notch1 agonist could be reversed by BTKi. Expression of RBP‐J protein decreased in alternative activated M2 macrophages by siRNA silencing Notch 1. Pretreatment with BTKi could down‐regulate the polarisation of M2 macrophages and reverse the resistance of DLBCL cells which were cocultured with alternative activated M2 macrophages to CAR‐T cells. This effect might be achieved by downregulating the Notch‐RBP‐J pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesLymphoma, Large B-Cell, DiffuseProtein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinaseImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansReceptor, Notch1Coculture TechniquesImmunoglobulin J Recombination Signal Sequence-Binding ProteinAdenineCell Line, TumorPiperidinesMacrophage ActivationDown-RegulationTumor MicroenvironmentNitric Oxide Synthase Type IIPyrimidines

Stichwörter der Autor:innen

Bruton's tyrosine kinase inhibitorchimeric antigen receptordiffuse large B‐cell lymphoma cellsmacrophages

Substanzen

Receptor, Notch1Immunoglobulin J Recombination Signal Sequence-Binding ProteinAdenineProtein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinasePiperidinesRBPJ protein, humanibrutinibNOTCH1 protein, humanNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Department of Hematology, Tianjin First Central Hospital, School of Medicine and Nankai University, Tianjin, China.
  • The First Central Clinical College of Tianjin Medical University, Tianjin, China.

ORCID-Profile: Yao Qi, Xin Li, Rui Cui, Qi Deng

Förderung

  • Tianjin Health Research Project
  • Chinese Society of Clinical Oncology Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Qi, Y., Fan, X., Wang, J., Li, X., Mu, J., Cui, R., & Deng, Q. (2026). Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR ‐T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages. Journal of Cellular and Molecular Medicine, 30(15). https://doi.org/10.1111/jcmm.71296

Vancouver

Qi Y, Fan X, Wang J, Li X, Mu J, Cui R, et al. Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR ‐T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages. Journal of Cellular and Molecular Medicine. 2026;30(15). doi:10.1111/jcmm.71296

BibTeX
@article{Qi2026,
  author = {Qi, Yao and Fan, Xuemei and Wang, Jia and Li, Xin and Mu, Juan and Cui, Rui and Deng, Qi},
  title = {Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR ‐T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {15},
  doi = {10.1111/jcmm.71296}
}
Kostenlos starten →